Sectors
Viracta Therapeutics will license its lead drug candidate to NantKwest, which is leading a series B round Viracta has said could reach $18.4m.
The home healthcare specialist has taken its overall funding to $35m with a Mahindra and Mahindra-led series B round that will support expansion.
IDG Capital-backed Xiaolu Yiguan, which offers traditional Chinese medicine and health consultancy, has raised 14.5m in a round co-led by Redpoint Ventures and Sinovation Ventures.
The internet-of-things technology developer has raised cash in a round co-led by Verizon that included Intel, JetBlue, CME Group, Flextronics and Samsung.
SoftBank and Cainiao Network have co-led the round, which follows a $5m series A secured two years ago from ZTE and a $1m angel round in 2014.
Optum Ventures added $7.5m to help life sciences data platform Shyft Analytics close a $20m series B round with backing from McKesson and Medidata.
The online meat retailer will use the funding, provided by investors including Sistema and Doosan, to expand geographically and improve its back-end technology.
Existing investors Nvidia and Verizon came back for a round that boosted the graphical data analysis platform's overall funding to $36.5m.
The corporate venturing unit led a $25m extension to the freight services platform's series B round, doubling its overall funding.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
